Bingqing Hui

Jiangsu Provincial Key Laboratory Of Chronic Digestive Diseases
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Targeting PTDSS1 to modulate GSH synthesis triggers mitophagy and induces ferroptosis in esophageal squamous cell carcinoma cells.

Targeting PTDSS1 to modulate GSH synthesis triggers mitophagy and induces ferroptosis in esophageal squamous cell carcinoma cells.

Journal: Cell death & disease

Published: June 19, 2025

Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085.

Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085.

Journal: Journal of nanobiotechnology

Published: September 29, 2023

Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial.

Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial.

Journal: Journal for immunotherapy of cancer

Published: December 29, 2022

CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy.

CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy.

Journal: Oncoimmunology

Published: September 12, 2022

Inhibition of APOE potentiates immune checkpoint therapy for cancer.

Inhibition of APOE potentiates immune checkpoint therapy for cancer.

Journal: International journal of biological sciences

Published: December 15, 2021

CircETFA upregulates CCL5 by sponging miR-612 and recruiting EIF4A3 to promote hepatocellular carcinoma.

CircETFA upregulates CCL5 by sponging miR-612 and recruiting EIF4A3 to promote hepatocellular carcinoma.

Journal: Cell death discovery

Published: August 14, 2021

Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: a case report.

Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: a case report.

Journal: Immunotherapy

Published: August 09, 2021

A novel regulatory mechanism network mediated by lncRNA TUG1 that induces the impairment of spiral artery remodeling in preeclampsia.

A novel regulatory mechanism network mediated by lncRNA TUG1 that induces the impairment of spiral artery remodeling in preeclampsia.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 03, 2021

Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.

Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.

Journal: Journal of cellular physiology

Published: May 09, 2021

Application of Animal Models in Cancer Research: Recent Progress and Future Prospects.

Application of Animal Models in Cancer Research: Recent Progress and Future Prospects.

Journal: Cancer management and research

Published: January 20, 2021

Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma.

Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma.

Journal: Frontiers in oncology

Published: December 30, 2020

Correction: Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.

Correction: Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.

Journal: Molecular omics

Published: February 25, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026